Endospan Ltd.
USPTO PatentsView assignee record - 32 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Endospan ranks #9,755 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 5 technology areas.
- #9,755
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (39.8/100)
- 25.8
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9755 · Foreign Corporation #9,755 · 32 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 32 grants
- UPPER-Q #9,755/49,997
- PHOTO-FINISH DGS Global Systems
- CPC-NARROW A61F · 5 areas
- INNOV-THIN 39.8/100
- CLAIMS-DENSE 25.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: DGS Global Systems, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Endospan’s 39.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Endospan
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Delphi Automotive… · near
Delphi Automotive… · near
40 score
- Endospan · this assignee
Endospan · this assignee
40 score
- Flisom · near
Flisom · near
40 score
- Octapharma · near
Octapharma · near
40 score
- Polymer Technology… · near
Polymer Technology… · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Endospan's Innovation Score is 39.8/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Endospan?
Each dot is one of Endospan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Endospan’s own 25.8 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Endospan's grants concentrate
Endospan Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2020. By volume, Endospan sits between DGS Global Systems, Inc. and Edwards Lifesciences Innovation (Israel) Ltd..
Endospan's three-year grant acceleration
Endospan Ltd. shows 5 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Endospan's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- DGS Global Systems
DGS Global Systems, Inc.
32 patents
- Dr Py Institute
Dr. Py Institute LLC
32 patents
- Elbi Internationa…
Elbi International S.P.A
32 patents
- Elite Material (K…
Elite Electronic Material (KUNSHAN) Co., Ltd.
32 patents
- ETS Express
ETS Express, LLC
32 patents
- ETS Lindgren
ETS Lindgren Inc.
32 patents
- Eurofilters Holdi…
Eurofilters Holding N.V.
32 patents
- Edwards Lifescien…
Edwards Lifesciences Innovation (Israel) Ltd.
32 patents
- Endospan ◀
Endospan Ltd.
32 patents
What this shows Endospan holds 32 patents at rank #9,752, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Endospan
By rank, the assignees closest to #9,752 in granted patent volume.
- DGS Global Systems, Inc. #9,748 · 32 patents
- Dr. Py Institute LLC #9,749 · 32 patents
- Elbi International S.P.A #9,750 · 32 patents
- Elite Electronic Material (KUNSHAN) Co., Ltd. #9,751 · 32 patents
- ETS Express, LLC #9,753 · 32 patents
- ETS Lindgren Inc. #9,754 · 32 patents
- Eurofilters Holding N.V. #9,755 · 32 patents
- Edwards Lifesciences Innovation (Israel) Ltd. #9,756 · 32 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Endospan's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Endospan, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Endospan ranks #197 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Endospan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 15.6% |
| 2016 | 6 | 18.8% |
| 2017 | 4 | 12.5% |
| 2018 | 3 | 9.4% |
| 2019 | 2 | 6.3% |
| 2020 | 1 | 3.1% |
| 2021 | 4 | 12.5% |
| 2022 | 2 | 6.3% |
| 2023 | 1 | 3.1% |
| 2024 | 2 | 6.3% |
| 2025partial year | 2 | 6.3% |
Which technologies does Endospan Ltd. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Endospan Ltd.'s patent record in context - here's where to go next.
- Endospan Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #9,755 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Endospan Ltd. against DGS Global Systems, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.